CD274 and neoplasm: However, the value of tumor molecular or clinicopathological characteristics such as programmed death-ligand 1 (PD-L1), microsatellite stability (MSI), and tumor mutational burden (TMB) is limited because of the heterogeneity of tumors and tumor microenvironment (TME), among other reasons [5, 6].